Evaluation of myocardial function and structure in valvular heart disease: what is needed for risk assessment and

Erwan Donal1, Marina Petersen Saadi1, Marc Dweck2

  • 1University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, 2 rue Henri le Guilloux, 35033, Rennes F-35000, France.

Insights

Valvular heart disease (VHD) is a myocardial disease. New imaging tools detect heart muscle injury early, enabling better management focused on the ventricle, not just the valve.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Biomedical Engineering

Background:

  • Traditional valvular heart disease (VHD) assessment focuses on valve function, often missing early myocardial injury.
  • Emerging evidence classifies VHD as a myocardial disease, where ventricular response significantly impacts outcomes.
  • Current methods may fail to detect dysfunction until advanced stages.

Purpose of the Study:

  • To redefine VHD assessment through a myocardium-first approach.
  • To highlight advanced imaging tools for early detection of myocardial dysfunction in VHD.
  • To propose a new management strategy centered on myocardial protection.

Main Methods:

  • Review of contemporary evidence and state-of-the-art imaging techniques.
  • Focus on specific myocardial strain parameters: LV global longitudinal strain (LV-GLS), RV strain with RV-PA coupling, and LA reservoir strain.
  • Integration of cardiac magnetic resonance (CMR) parameters (native T1, ECV, LGE) and next-generation technologies (CT-ECV, molecular imaging, AI).

Main Results:

  • A triad of strain measures (LV-GLS, RV-PA coupling, LA strain) detects myocardial injury early and improves prognostic accuracy.
  • CMR identifies diffuse and focal fibrosis, crucial for understanding remodeling.
  • Advanced technologies like CT-ECV, molecular imaging, and AI offer scalable and personalized risk assessment.

Conclusions:

  • VHD management should prioritize myocardial health, shifting focus from valve correction to ventricle protection.
  • A serial, multiparametric, AI-enhanced strategy utilizing advanced imaging can guide interventions during the optimal therapeutic window.
  • This myocardium-centric approach is essential for preserving cardiac function in VHD patients.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
399
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
209
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
317
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
242
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
470
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
237